Coronavirus (Covid-19): Latest updates and information
Skip to main content Skip to navigation

Warwick Ventures Licensing Opportunities - School of Life Sciences

Select tags to filter on

Rapid diagnostic test for SARS-CoV-2

Coronavirus diagnostics currently require centralised facilities and collection/distribution of swabs and results are ‘next day’. A new diagnostic tool being developed by the University of Warwick and its partner Iceni Diagnostics may allow on-the-spot detection of Coronavirus infection, without facilities using a simple disposable device.

More details: Rapid diagnostic test for SARS-CoV-2

Contact: Dr James Lapworth, Warwick Ventures email: j.lapworth@warwick.ac.uk

Tue 16 Jun 2020, 13:51 | Tags: Life Sciences and Biotechnology, Diagnostic

IVF pre-implantation screening method

A team at the University of Warwick has developed a new screening test that potentially provides an accurate and noninvasive method for assessing embryos during IVF treatment, prior to implantation.

More details: IVF pre-implantation screening method

Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk

Thu 17 Dec 2015, 11:38 | Tags: Life Sciences and Biotechnology

Increased Epigenetic Variation in Plants

A team at the University of Warwick has developed technology to increase the epigenetic variety of plants without the usual undesired side effects. The novel strategy allows a much greater range of epigenetic and phenotypic differences to be introduced than was previously possible.

More details: Increased epigenetic variation in plants

Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk

Mon 23 Nov 2015, 16:02 | Tags: Life Sciences and Biotechnology

Older news